Ling Morgan is an accomplished professional with extensive experience in bioanalytics and biomarker development. Currently serving as the Director of Quantitative Bioanalytics at Moderna since July 2022, Ling also holds the position of Director of Bioanalytical & Biomarker Development at Wave Life Sciences since April 2021. Previous roles include Associate Director, CBID at Takeda and NCE Bioanalysis Lead at Shire. Ling's career began at Agilux Laboratories as Associate Director and Principal Scientist III, following tenures as Group Leader at Tandem Labs and Scientist I at BD Bioscience. Ling has a strong foundation in analytical chemistry, holding a Ph.D. from The University of New Mexico and a Bachelor's Degree from Jilin University.
This person is not in any teams
This person is not in any offices